These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27585059)

  • 1. Emerging therapeutics for ocular surface disease.
    Bielory BP; Shah SP; O'Brien TP; Perez VL; Bielory L
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):477-86. PubMed ID: 27585059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options and emerging therapies for anterior ocular inflammatory disease.
    Syed BA; Kumar S; Bielory L
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):485-9. PubMed ID: 25102104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
    Becker Y
    Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye.
    Villani E; Mantelli F; Nucci P
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):569-76. PubMed ID: 23974688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of anterior ocular inflammatory disease.
    Bielory L; Syed BA
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):537-42. PubMed ID: 23945174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T helper subsets in allergic eye disease.
    Reyes NJ; Saban DR
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):477-84. PubMed ID: 25111509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular allergy as a risk factor for dry eye in adults and children.
    Villani E; Rabbiolo G; Nucci P
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):398-403. PubMed ID: 30015640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular biomarkers in dry eye disease and ocular allergy.
    Enríquez-de-Salamanca A; Bonini S; Calonge M
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):523-33. PubMed ID: 22895048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of allergy in the real world.
    Ohta K
    Allergol Int; 2014 Sep; 63(3):291-2. PubMed ID: 25317459
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular evidence for the role of inflammation in dry eye disease.
    Ganesalingam K; Ismail S; Sherwin T; Craig JP
    Clin Exp Optom; 2019 Sep; 102(5):446-454. PubMed ID: 30630216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.
    Pflugfelder SC; Stern M; Zhang S; Shojaei A
    J Ocul Pharmacol Ther; 2017; 33(1):5-12. PubMed ID: 27906544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapies in allergic conjunctivitis and dry eye syndrome.
    Nye M; Rudner S; Bielory L
    Expert Opin Pharmacother; 2013 Aug; 14(11):1449-65. PubMed ID: 23822862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allergies: determinants of T2 lymphocyte polarization and desensitization mechanisms].
    Magnan A; Vervloet D
    Rev Mal Respir; 1997 Jun; 14(3):173-81. PubMed ID: 9411594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the diagnosis and therapy for diseases of the ocular surface: dry eye and ocular allergies].
    Messmer EM; Benitez del Castello J; Lambiase A; Doan S
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):643-9. PubMed ID: 16927218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hot Topics in Dry Eye Disease.
    Chiaradia PA; Zeman Bardeci LA; Dankert S; Mendaro MO; Grzybowski A
    Curr Pharm Des; 2017; 23(4):608-623. PubMed ID: 27928967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry eye disease as an inflammatory disorder.
    Calonge M; Enríquez-de-Salamanca A; Diebold Y; González-García MJ; Reinoso R; Herreras JM; Corell A
    Ocul Immunol Inflamm; 2010 Aug; 18(4):244-53. PubMed ID: 20482396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.